Source: Eur Respir J 2009; 33: 708-709
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Keene O. N., Celli B., Anderson J. A., Ferguson G. T., Jenkins C. R., Jones P. W., Vestbo J., Knobil K., Yates J. C., Calverley P. M. A.. Lung function decline in COPD trials. Eur Respir J 2009; 33: 708-709

Member's Comments

No comment yet.

Related content which might interest you: Lung function decline in asthma Source: Eur Respir J 2007; 30: 411-413 Year: 2007 Lung function decline in patients with bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Lung function decline in COPD trials: bias from regression to the mean Source: Eur Respir J 2008; 32: 829-831 Year: 2008 Lung hyperinflation is a determinant of the heart rate recovery delay in COPD patients Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Lung function and exercise capacity in COPD phenotypes with and without emphysema Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: ERS Live 2008 Year: 2008 Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: Guideline 2008 Year: 2008 COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Measurement of lung function deterioration in COPD by V/P SPECT Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Lung function impairment, COPD hospitalisations and subsequent mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Lung volume reduction effect after lobectomy in COPD patients Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome Year: 2013 Lung function decline in long-term follow-up of bronchial asthma Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010